Connect Biopharma Holdings Limited (CNTB) Free cash flow 2023–2025
Connect Biopharma Holdings Limited (CNTB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.6MFY2025 · since FY2023: -$47.8M → -$51.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.6M | -112.0% |
| FY2024 | -$24.4M | +49.1% |
| FY2023 | -$47.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CNTB financial trends
CNTB RevenueCNTB Net incomeCNTB Net marginCNTB Gross profitCNTB Gross marginCNTB Operating incomeCNTB Operating marginCNTB Operating cash flowCNTB Capital expendituresCNTB Return on equityCNTB Stock buybacksCNTB Dividends paidCNTB Total assetsCNTB Total liabilitiesCNTB Shareholders’ equityCNTB overview →